{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:45:34Z","timestamp":1792806334839,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.vaccine.2017.06.070","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T04:33:11Z","timestamp":1499920391000},"page":"4646-4651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"PB","title":["Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children"],"prefix":"10.1016","volume":"35","author":[{"given":"Jesus","family":"Ruiz-Contreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Picazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Casado-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Baquero-Artigao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Hern\u00e1ndez-Sampelayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Otheo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Amo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Balseiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2017.06.070_b0005","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"21","key":"10.1016\/j.vaccine.2017.06.070_b0010","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998\u20132007","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"issue":"9854","key":"10.1016\/j.vaccine.2017.06.070_b0015","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(12)61187-8","article-title":"Effect of vaccines on bacterial meningitis worldwide","volume":"380","author":"McIntyre","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2017.06.070_b0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1473-3099(14)70805-9","article-title":"Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population-based observational study","volume":"14","author":"Castelblanco","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.06.070_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","article-title":"Community-acquired bacterial meningitis in adults in the Netherlands, 2006\u201314: a prospective cohort study","volume":"16","author":"Bijlsma","year":"2016","journal-title":"Lancet Infect Diseas"},{"issue":"3","key":"10.1016\/j.vaccine.2017.06.070_b0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1542\/peds.2013-0621","article-title":"Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997\u20132010 in Utah","volume":"132","author":"Stockmann","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2017.06.070_b0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.070_b0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1473-3099(10)70048-7","article-title":"Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis","volume":"10","author":"Edmond","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.070_b0045","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/cid\/civ368","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children","volume":"61","author":"Olarte","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.06.070_b0050","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.06.070_b0055","unstructured":"CDC. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease \u2013 United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005;54(36):893\u20137."},{"issue":"18","key":"10.1016\/j.vaccine.2017.06.070_b0060","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.070_b0065","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Munoz-Almagro","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.06.070_b0070","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999\u20132011(1.)","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2017.06.070_b0075","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1469-0691.2006.1502_1.x","article-title":"Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine","volume":"12","author":"Calbo","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2017.06.070_b0080","unstructured":"Barricarte A, Gil-Setas A, Torroba L, et al. Invasive pneumococcal disease in children younger than 5 years in Navarra, Spain (2000-2005). Impact of the conjugate vaccine. Med Clin (Barc.) 2007;129(2):41\u20135."},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.070_b0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jinf.2011.06.002","article-title":"Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain","volume":"63","author":"Munoz-Almagro","year":"2011","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2017.06.070_b0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/CVI.00317-10","article-title":"Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar","volume":"18","author":"Picazo","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2017.06.070_b0095","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JCM.02498-06","article-title":"Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA","volume":"45","author":"Carvalho Mda","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.06.070_b0100","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/JCM.39.4.1553-1558.2001","article-title":"Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR","volume":"39","author":"Corless","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2017.06.070_b0105","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1469-0691.2008.02028.x","article-title":"Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR","volume":"14","author":"Tarrago","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2017.06.070_b0110","unstructured":"Institute CaLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard M7\u2013A7. CLSI, Wayne, PA; 2006."},{"key":"10.1016\/j.vaccine.2017.06.070_b0115","series-title":"Performance standards for antimicrobial susceptibility testing: 19th informational supplement M100\u2013S19","first-page":"2009","author":"Intitute. CaLS","year":"2009"},{"key":"10.1016\/j.vaccine.2017.06.070_b0120","doi-asserted-by":"crossref","first-page":"4850","DOI":"10.1016\/j.vaccine.2016.08.069","article-title":"Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditions","volume":"34","author":"Cohen","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.06.070_b0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/cid\/civ692","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children","volume":"62","author":"Levy","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.06.070_b0130","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","article-title":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: comparison between meningitis and non-meningitis IPD","volume":"34","author":"Ben-Shimol","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.06.070_b0135","doi-asserted-by":"crossref","unstructured":"Ben-Shimol S, Givon-Lavi N, Grisaru-Soen G, et al. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: insights from Israeli surveillance studies. Vaccine; 2017. http:\/\/dx.doi.org\/10.1016\/j.vaccine.2017.05.059 [Epub ahead of print].","DOI":"10.1016\/j.vaccine.2017.05.059"},{"issue":"12","key":"10.1016\/j.vaccine.2017.06.070_b0140","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/INF.0000000000000451","article-title":"Trends of pneumococcal meningitis in children after introduction of the 13-valent pneumococcal conjugate vaccine in France","volume":"33","author":"Levy","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2017.06.070_b0145","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1542\/peds.2008-1702","article-title":"Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children","volume":"125","author":"Kaplan","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.070_b0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jinf.2009.05.012","article-title":"Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona","volume":"59","author":"Munoz-Almagro","year":"2009","journal-title":"J Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2017.06.070_b0155","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.vaccine.2010.12.114","article-title":"Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: a 2-year (2007\u20132009) laboratory-based surveillance in Madrid","volume":"29","author":"Picazo","year":"2011","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.070_b0160","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/498043","article-title":"Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States","volume":"192","author":"Pai","year":"2005","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2017.06.070_b0165","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/INF.0b013e31803df9ca","article-title":"Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine","volume":"26","author":"Pelton","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.06.070_b0170","doi-asserted-by":"crossref","unstructured":"Metcalf BJ, Gertz RE Jr., Gladstone RA, et al. Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA. Clin Microbiol Infect 2016;22(1):60 e69\u201329.","DOI":"10.1016\/j.cmi.2015.08.027"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.070_b0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome","volume":"28","author":"Ruckinger","year":"2009","journal-title":"Pediat Infect Dis J."},{"issue":"6","key":"10.1016\/j.vaccine.2017.06.070_b0180","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/655828","article-title":"Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.06.070_b0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/518538","article-title":"Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study","volume":"45","author":"Alanee","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.070_b0190","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.06.070_b0195","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/cid\/cit791","article-title":"Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5\u201315 years in England and Wales","volume":"58","author":"Ladhani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.070_b0200","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/cid\/ciu348","article-title":"Risk of pneumococcal disease in children with chronic medical conditions in the era of pneumococcal conjugate vaccine","volume":"59","author":"Pelton","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.06.070_b0205","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/JCM.06087-11","article-title":"Clinical validation of multiple real-time PCR assays for detection of bacterial meningitis pethogens","volume":"50","author":"Wang","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.06.070_b0210","doi-asserted-by":"crossref","first-page":"e20675","DOI":"10.1371\/journal.pone.0020675","article-title":"Incorporation of real-time PCR into routine public health surveillance culture negative bacterial meningitis in Sao Paulo, Brazil","volume":"6","author":"Sacchi","year":"2011","journal-title":"PLOS one"},{"key":"10.1016\/j.vaccine.2017.06.070_b0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2334-13-26","article-title":"Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis","volume":"13","author":"Wu","year":"2013","journal-title":"BMC Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T19:46:42Z","timestamp":1569786402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17308678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":43,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0264410X17308678"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}